Pharmaceutical Sex Raw Flibanserin Powder for Female Sexual Desire 167933-07-5

313 views 0 replies
Reply to Topic
freemexy

Age: 2023
Total Posts: 0
Points: 10

Location:
,
Pharmaceutical Sex Raw Flibanserin Powder for Female Sexual Desire 167933-07-5

Flibanserin hydrochloride powder (INN, USAN), sold under the trade name Addyi, is a medication approved
for the treatment of pre-menopausal women with hypoactive sexual desire
disorder (HSDD).The medication increases the number of satisfying sexual
events per month by about one half to one over placebo from a starting
point of about two to three.


Flibanserin ( Addyi ) is a new drug being investigated for the prevention of HSDD in woman. HSDD, is a relatively new term developed to
describe Hypoactive Sexual Desire Disorder which basically means a
woman whose is otherwise healthy has a lacking libido, or a lack of
sexual desire. Studies show that about 10-20% of women face this problem
and some say HSDD outnumbers men with sexual problems.Flibanserin is
classified as a 5-HT serotonin receptor agonist and a dopamine D4
receptor partial agonist. It is a Non-Hormonal agent that in essence
increases dopamine and noradrenalin while reducing Serotonin in the
brain. This in return seemingly has a positive effect on a woman's
sexual craving who was otherwise lacking in this area. The benefits of
it being Non-Hormonal are that it will not have the problems associated
with other hormonal treatments such as a negative altered mood among
other issues.


Medical use:

Flibanserin is used for hypoactive sexual desire disorder among women. Those receiving flibanserin report a 0.5 increase compared to
placebo in the number of times they had "satisfying sexual events". In
those on flibanserin it rose from 2.8 to 4.5 times a month while women
receiving placebo reported also an increase of "satisfying sexual
events" from 2.7 to 3.7 times a month. The onset of the flibanserin
effect was seen from the first timepoint measured after 4 weeks of
treatment and maintained throughout the treatment period.

Dosage:
(1) Recommended dosage is 100 mg taken once daily at bedtime.
(2) Taking it at night reduces the risk of sleepiness, low blood pressure, and fainting during waking hours.
(3) If your symptoms do not improve after 8 weeks of treatment, stop treatment and call your doctor.
(4) If a dose is missed at bedtime, take the next dose at bedtime the following day. Do not take a double
dose to make up for a missed one.

Posted 11 Sep 2019

Reply to Topic